EUVIMEDEUVIMED entdecken
Open Access

PARP1 suppression drives ROS resistance in aneuploid cancer cells

Pan Cheng, Angela Mermerian-Baghdassarian, Yufeng Wang, Ze Chen, Helberth M Quysbertf, Pradeep Singh Cheema, Joseph C Mays, Xin Zhao, Lizabeth Katsnelson, Sally Mei, Rohini Shrivastava, Mirna Bulatovic und 4 weitere

Molecular Cell · 2026-05 · 86 (9) · 1742-1761.e19

DOI: 10.1016/j.molcel.2026.04.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2026-05. Verfasst von Pan Cheng und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine, New York, NY 10016, USA; D…. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Poly (ADP-Ribose) Polymerase-1, Aneuploidy, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHGRI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aneuploidy is common in cancer and has been implicated in promoting tumor progression, yet the underlying mechanisms remain poorly understood. By generating models of aneuploidy, we found that aneuploidy confers resistance to reactive oxygen species (ROS)-mediated cell death, independent of the specific chromosomes gained or lost. Mechanistically, poly(ADP-ribose) polymerase 1 (PARP1) is suppressed in aneuploid cells, which inhibits PARP1-mediated cell death (parthanatos). We validated aneuploidy-associated PARP1 suppression across 15 cell models and human tumors, with pronounced effects in metastatic tumors. Importantly, PARP1 downregulation promotes tumor metastasis while PARP1 upregulation suppresses it. Through a genome-wide CRISPR screen and functional validation, we identified the transcription factor CCAAT/enhancer-binding protein beta (CEBPB) as a mediator of PARP1 downregulation and ROS resistance in aneuploid cells. Lysosomal dysfunction serves as the upstream activator of CEBPB in aneuploid cells. We propose that aneuploidy-driven CEBPB activation suppresses PARP1, fostering ROS resistance and cancer progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesPoly (ADP-Ribose) Polymerase-1AneuploidyNeoplasmsHumansAnimalsCell Line, TumorCCAAT-Enhancer-Binding Protein-betaGene Expression Regulation, NeoplasticParthanatosMiceDown-RegulationOxidative Stress

Stichwörter der Autor:innen

PARP1aneuploidycancercell deathoxidative stress

Substanzen

Reactive Oxygen SpeciesPoly (ADP-Ribose) Polymerase-1PARP1 protein, humanCCAAT-Enhancer-Binding Protein-beta

Autor:innen und Institutionen

  • Institute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine, New York, NY 10016, USA; Division of Hematology & Medical Oncology, Laura and Isaac Perlmutter C…
  • Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY 10016, USA.
  • Loxo Oncology at Lilly, Alexandria Center for Life Science, New York, NY 10016, USA.
  • Division of Hematology & Medical Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY 10016, USA.
  • Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY 10016, USA; Department of Cell Biology, NYU Grossman School of Medicine, New York, NY 10016, USA.

Förderung

  • NCI NIH HHS
  • NHGRI NIH HHS
  • NIDDK NIH HHS
  • National Cancer Institute Division of Cancer Prevention
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • The Pershing Square Foundation

Zitieren

APA

Cheng, P., Mermerian-Baghdassarian, A., Wang, Y., Chen, Z., Quysbertf, H. M., Cheema, P. S., Mays, J. C., Zhao, X., Katsnelson, L., Mei, S., Shrivastava, R., Bulatovic, M., Deng, J., Schober, M., Wong, K. K., & Davoli, T. (2026). PARP1 suppression drives ROS resistance in aneuploid cancer cells. Molecular Cell, 86(9), 1742-1761.e19. https://doi.org/10.1016/j.molcel.2026.04.006

Vancouver

Cheng P, Mermerian-Baghdassarian A, Wang Y, Chen Z, Quysbertf HM, Cheema PS, et al. PARP1 suppression drives ROS resistance in aneuploid cancer cells. Molecular Cell. 2026;86(9):1742-1761.e19. doi:10.1016/j.molcel.2026.04.006

BibTeX
@article{Cheng2026,
  author = {Cheng, Pan and Mermerian-Baghdassarian, Angela and Wang, Yufeng and Chen, Ze and Quysbertf, Helberth M and Cheema, Pradeep Singh and Mays, Joseph C and Zhao, Xin and Katsnelson, Lizabeth and Mei, Sally and Shrivastava, Rohini and Bulatovic, Mirna and Deng, Jiehui and Schober, Markus and Wong, Kwok-Kin and Davoli, Teresa},
  title = {PARP1 suppression drives ROS resistance in aneuploid cancer cells},
  journal = {Molecular Cell},
  year = {2026},
  volume = {86},
  number = {9},
  pages = {1742--1761.e19},
  doi = {10.1016/j.molcel.2026.04.006}
}
Kostenlos starten →